Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
4 reports, 3 independent
Updated Sep 11
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BofA raised its target price for Elevance Health while NPS reduced its stock stake.1 source
Analyst reports raise price targets for Elevance Health.1 source
Keep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
Elevance Health, Inc.
American healthcare company
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Analyst rating targets are affecting stock prices, and required reports regarding ownership stakes are being filed with the SEC for Bank of America and KBR, Inc.
- Analyst raised rating and price target for Atlas Energy Solutions on August 3, 2026, involving Raymond James Financial and RBC.
- MarketBeat aggregated analyst ratings for SM Energy, noting an upgrade from Truist Financial and a rating change from Raymond James Financial.
- Analyst reports are influencing stock price targets for Canadian Natural Resources.
- Bank of America analysts raised price targets for several U.S. industrial and healthcare stocks in July 2025.